GYRE Gyre Therapeutics Inc
127
$14.43
$0.19
(1.33%)
| Watchers | 127 |
| 52-Wk Low | $3.15 |
| 52-Wk High | $30.40 |
| Market Cap | $1.22B |
| Volume | 38,860.00 |
| 52-Wk High | $30.40 |
| 52-Wk Low | $3.15 |
Gyre Therapeutics (GYRE, $15.85) price exceeded its 50-day Moving Average on April 01, 2024Tickeron - Stocks • about 2 months ago
This price move could indicate a change in the trend, and may be a sell signal for investors...
Share to Feed
Transformational Year with Strategic Shifts and Clinical AdvancesRelated Stocks: GYRE...
Data readout from Phase 3 clinical trial in the People's Republic of China ( PRC ) evaluating F351 for the treatment of CHB-associated liver fibrosis expected by early 2025 U.S. Phase 2a clinical...
Gyre Therapeutics GAAP EPS of -$1.41, revenue of $113.5M...
SAN DIEGO, March 21, 2024 (GLOBE NEWSWIRE) -- Gyre Therapeutics ( Gyre ) (Nasdaq: GYRE), a clinical-stage biotechnology company developing anti-fibrotic therapeutics for a variety of chronic organ...
This price move could indicate a change in the trend, and may be a sell signal for investors...
This price move could indicate a change in the trend, and may be a sell signal for investors...
This is a signal that GYRE's price could be shifting from an uptrend to a downtrend. Traders may consider selling the stock or exploring put options...
This price move could indicate a change in the trend, and may be a sell signal for investors...
This is a signal that GYRE's price could be shifting from an uptrend to a downtrend. Traders may consider selling the stock or exploring put options...